Viewing Study NCT05276492


Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2025-12-27 @ 3:50 PM
Study NCT ID: NCT05276492
Status: TERMINATED
Last Update Posted: 2025-10-03
First Post: 2022-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.
Sponsor: University of Chicago
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module